Trial intelligence / Profile preview

MAL-PDT in Moderate to Severe Acne

NCT00594425Phase 2Completed

Sponsor
Photocure
Start
Feb 2007
Primary completion
Jul 2008
Modality
Light/Condition-Responsive Prodrugs
Countries
1
01

Overview

A Phase 2 trial of methyl aminolevulinate in acne vulgaris, sponsored by Photocure. Started Feb 2007; status: completed.

02

Drugs

methyl aminolevulinate
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT00594425.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00594425.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call